首页
400-620-6333
抗体
选项
-
Gemtuzumab (anti-CD33)关联靶标: CD33
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 220578-59-6 -
Lintuzumab (anti-CD33)关联靶标: CD33
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level < 0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 166089-32-3 -
CD33 Mouse mAb关联靶标: CD33
- 简短描述: mAb (HIM3-4); Mouse anti Human CD33 Antibody; Flow; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: HIM3-4
- 偶联: Unconjugated
-
Astegolimab (anti-IL-1RL1)关联靶标: IL1RL1
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG2
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2173054-79-8 -
Melrilimab (anti-IL-33R)关联靶标: IL1RL1
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2222865-46-3 -
ST2 Mouse mAb关联靶标: IL1RL1
- 简短描述: mAb (18H10E6); Mouse anti Human ST2 Antibody; Capture Antibody, ELISA, FIA; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG
- 宿主种属: 小鼠(Mouse)
- 克隆号: 18H10E6
- 偶联: Unconjugated
-
ST2 Mouse mAb关联靶标: IL1RL1
- 简短描述: mAb (11H10E3); Mouse anti Human ST2 Antibody; Detection Antibody, ELISA, FIA; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG
- 宿主种属: 小鼠(Mouse)
- 克隆号: 11H10E3
- 偶联: Unconjugated
-
Vadastuximab (anti-CD33)关联靶标: CD33
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1436390-64-5
